Locations:

Cancer

April 27, 2018/Basic & Translational Science

Mutations in Aplastic Anemia Can Predict Increased Risk of Myelodysplastic Syndromes

Not all mutations are prognosticative

April 23, 2018/Basic & Translational Science

Turning Up the Heat on Glioblastoma with Thermal Medicine

Hyperthermia augments radiation therapy

April 17, 2018/Cancer/News & Insight

Should Adjuvant Radiotherapy Be the Gold Standard for High-Risk Post-Prostatectomy Patients?

New evidence supports ART, but caveats remain

April 12, 2018/Cancer/Research

Thyroid Cancer Treatment with Radioactive Iodine Increases Risk of Leukemia

Study shows risk of overtreating patients

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

April 10, 2018/Cancer/Research

STRIVE Study Supports Development of a Blood Test for Early Breast Cancer Detection

Investigating cell-free nucleic acids for cancer detection

April 9, 2018/Basic & Translational Science

Vasorin: The Achilles’ Heel of Glioma Stem Cells

Hypoxic induction of vasorin regulates Notch1 turnover

April 9, 2018/Cancer

Cleveland Clinic Develops First Overall Risk Prediction Model for Cervical Cancer

Accurate risk prediction reduces costs and false positives

April 5, 2018/Cancer/Research

How a Myelofibrosis Drug PERSISTed Through an FDA Hold

Final results of PERSIST-2 confirm benefit; PAC203 enrolling

April 4, 2018/Cancer/News & Insight

Social Media and Journal Clubs: The Ultimate Peer Review?

An oncologist weighs in

April 2, 2018/Cancer

FDA Approval of Apalutamide: Practical Implications

The first approved treatment for men with nonmetastatic castration-resistant prostate cancer (M0CRPC)

BackPage 88 of 113Next